Filing Flows › Inspire Medical Systems (INSP) › Q3 2026
Inspire Medical Systems (INSP) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 2, 2026
Inspire Medical Systems (INSP) reported revenue of $207M for the third quarter 2026 (Q3 2026), -8% from a year earlier and +3% from the quarter before. Operating margin was -13.9%, net loss $24.4M (11.8% of revenue).
Inspire Medical Systems, Q3 2026: revenue $207M (-8% year over year), operating margin -13.9%, net loss $24.4M, operating cash flow $46.4M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $207M | +3% | -8% |
| Operating profit | −$28.7M | — | -398% |
| Net earnings | −$24.4M | -7869% | -346% |
| Operating cash flow | $46.4M | +100% | -32% |
| Free cash flow | $38.9M | +176% | -33% |
What changed
Revenue was $206.7M in Q3 2026, down 8% year over year and up 3% from the previous quarter.
Gross margin was 86.0%, up 0.2 points from Q3 2025. Operating costs exceeded revenue by $28.7M, an operating margin of -13.9%. Operating expenses grew 13% against a revenue fall of 8%. The fastest-growing cost line was SG&A (+16%). The quarter ended with a net loss of $24.4M, after a profit of $314K the previous quarter.
Operating cash flow was $46.4M (down 32% year over year). Non-cash charges added back $5.1M of depreciation and amortization and $26.9M of share-based compensation. Working capital and other items added $38.8M. Capital expenditures of $7.5M left free cash flow of $38.9M.
Questions
What was Inspire Medical Systems' revenue in the third quarter 2026?
Inspire Medical Systems (INSP) reported revenue of $207M for the third quarter 2026 (Q3 2026), -8% from a year earlier and +3% from the quarter before.
Was Inspire Medical Systems profitable in the third quarter 2026?
Operating loss was $28.7M (-13.9% of revenue) and net loss $24.4M.